Works by Xie, Wanling

Results: 44

CDK4/6 Inhibition With Abemaciclib in Patients With Previously Treated Advanced Renal Cell Carcinoma.

Published in:

Clinical Genitourinary Cancer, 2025, v. 23, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2025.102318

By:

McGregor, Bradley A.;
Xie, Wanling;
Berg, Stephanie A.;
Xu, Wenxin;
Viswanathan, Srinivas R.;
McDermott, David;
Signoretti, Sabina;
Kaelin, William G;
Choueiri, Toni K.

Publication type:

Article

Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.

Published in:

JNCI Cancer Spectrum, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/jncics/pkz002

By:

Xie, Wanling;
Halabi, Susan;
Tierney, Jayne F;
Sydes, Matthew R;
Collette, Laurence;
Dignam, James J;
Buyse, Marc;
Sweeney, Christopher J;
Regan, Meredith M

Publication type:

Article

Neoadjuvant Novel Hormonal Therapy Followed by Prostatectomy versus Up-Front Prostatectomy for High-Risk Prostate Cancer: A Comparative Analysis.

Published in:

AUANews, 2022, v. 27, p. 16

By:

Ravi, Praful;
Kwak, Lucia;
Wanling Xie;
Kelleher, Kaitlin;
Acosta, Andres M.;
McKay, Rana R.;
Kibel, Adam S.;
Taplin, Mary-Ellen

Publication type:

Article

Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.

Published in:

American Journal of Hematology, 2010, v. 85, n. 9, p. 670, doi. 10.1002/ajh.21788

By:

Ghobrial, Irene M.;
Xie, Wanling;
Padmanabhan, Swaminathan;
Badros, Ashraf;
Rourke, Meghan;
Leduc, Renee;
Chuma, Stacey;
Kunsman, Janet;
Warren, Diane;
Poon, Tiffany;
Harris, Brianna;
Sam, Amy;
Anderson, Kenneth C.;
Richardson, Paul G.;
Treon, Steven P.;
Weller, Edie;
Matous, Jeffrey

Publication type:

Article

Novel M-component based biomarkers in Waldenström's macroglobulinemia.

Published in:

2011

By:

Leleu, Xavier;
Koulieris, Efstathios;
Maltezas, Dimitrios;
Itzykson, Raphael;
Xie, Wanling;
Manier, Saolomon;
Dulery, Remy;
Boyle, Eilleen;
Gauthier, Jordan;
Poulain, Stéphanie;
Tatiana, Tzenou;
Panayiotidis, Panayiotis;
Bradwell, Arthur R.;
Harding, Stephen;
Leblond, Veronique;
Kyrtsonis, Marie-Christine;
Ghobrial, Irene M.

Publication type:

Journal Article

Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 164, doi. 10.3816/CLML.2011.n.039

By:

Leleu, Xavier;
Koulieris, Efstathios;
Maltezas, Dimitrios;
Itzykson, Raphael;
Xie, Wanling;
Manier, Salomon;
Dulery, Remy;
Boyle, Eilleen;
Gauthier, Jordan;
Poulain, Stéphanie;
Tatiana, Tzenou;
Panayiotidis, Panayiotis;
Bradwell, Arthur R.;
Harding, Stephen;
Leblond, Veronique;
Kyrtsonis, Marie-Christine;
Ghobrial, Irene M.

Publication type:

Article

Tracing the Timing of "Career" Acquisition in a Contemporary Youth Cohort.

Published in:

Work & Occupations, 2008, v. 35, n. 1, p. 44, doi. 10.1177/0730888407309761

By:

Mortimer, Jeylan T.;
Vuolo, Mike;
Staff, Jeremy;
Wakefield, Sara;
Wanling Xie

Publication type:

Article

The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).

Published in:

2015

By:

Sweeney, Christopher;
ICECaP Working Group;
Nakabayashi, Mari;
Regan, Meredith;
Xie, Wanling;
Hayes, Julia;
Keating, Nancy;
Li, Suhui;
Philipson, Tomas;
Buyse, Marc;
Halabi, Susan;
Kantoff, Philip;
Sartor, A Oliver;
Soule, Howard;
Mahal, Brandon

Publication type:

journal article

Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 7, p. 519, doi. 10.1093/jnci/djp030

By:

Migita, Toshiro;
Ruiz, Stacey;
Fornari, Alessandro;
Fiorentino, Michelangelo;
Priolo, Carmen;
Zadra, Giorgia;
Inazuka, Fumika;
Grisanzio, Chiara;
Palescandolo, Emanuele;
Shin, Eyoung;
Fiore, Christopher;
Wanling Xie;
Kung, Andrew L.;
Febbo, Phillip G.;
Subramanian, Aravind;
Mucci, Lorelei;
Jing Ma;
Signoretti, Sabina;
Stampfer, Meir;
Hahn, William C.

Publication type:

Article

Formal Verification of mCWQ Using Extended Hoare Logic.

Published in:

Mobile Networks & Applications, 2019, v. 24, n. 1, p. 134, doi. 10.1007/s11036-018-1142-8

By:

Xie, Wanling;
Zhu, Huibiao;
Wu, Xi;
Vinh, Phan Cong

Publication type:

Article

Modeling and Verifying Basic Modules of Floodlight.

Published in:

Mobile Networks & Applications, 2019, v. 24, n. 1, p. 100, doi. 10.1007/s11036-018-1141-9

By:

Xiang, Shuangqing;
Wu, Xi;
Zhu, Huibiao;
Xie, Wanling;
Xiao, Lili;
Vinh, Phan Cong

Publication type:

Article

Modeling and Verifying HDFS Using Process Algebra.

Published in:

Mobile Networks & Applications, 2017, v. 22, n. 2, p. 318, doi. 10.1007/s11036-017-0812-2

By:

Xie, Wanling;
Zhu, Huibiao;
Wu, Xi;
Xiang, Shuangqing;
Guo, Jian;
Vinh, Phan

Publication type:

Article

Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.

Published in:

Cancer (0008543X), 2021, v. 127, n. 6, p. 840, doi. 10.1002/cncr.33328

By:

McGregor, Bradley Alexander;
Campbell, Matthew T.;
Xie, Wanling;
Farah, Subrina;
Bilen, Mehmet A.;
Schmidt, Andrew L.;
Sonpavde, Guru P.;
Kilbridge, Kerry L.;
Choudhury, Atish D.;
Mortazavi, Amir;
Shah, Amishi Y.;
Venkatesan, Aradhana M.;
Bubley, Glenn J.;
Siefker‐Radtke, Arlene O.;
McKay, Rana R.;
Choueiri, Toni K.

Publication type:

Article

Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysis.

Published in:

2018

By:

Harshman, Lauren C.;
Xie, Wanling;
Moreira, Raphael B.;
Bossé, Dominick;
Ruiz Ares, Gustavo J.;
Sweeney, Christopher J.;
Choueiri, Toni K.;
Bossé, Dominick

Publication type:

journal article

Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Published in:

2016

By:

Kaymakcalan, Marina D.;
Xie, Wanling;
Albiges, Laurence;
North, Scott A.;
Kollmannsberger, Christian K.;
Smoragiewicz, Martin;
Kroeger, Nils;
Wells, J. Connor;
Rha, Sun‐Young;
Lee, Jae Lyun;
McKay, Rana R.;
Fay, André P.;
De Velasco, Guillermo;
Heng, Daniel Y. C.;
Choueiri, Toni K.

Publication type:

journal article

Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria.

Published in:

Cancer (0008543X), 2013, v. 119, n. 16, p. 2999, doi. 10.1002/cncr.28151

By:

Kroeger, Nils;
Xie, Wanling;
Lee, Jae‐Lyn;
Bjarnason, Georg A.;
Knox, Jennifer J.;
MacKenzie, Mary J.;
Wood, Lori;
Srinivas, Sandy;
Vaishamayan, Ulka N.;
Rha, Sun‐Young;
Pal, Sumanta K.;
Yuasa, Takeshi;
Donskov, Frede;
Agarwal, Neeraj;
Kollmannsberger, Christian K.;
Tan, Min‐Han;
North, Scott A.;
Rini, Brian I.;
Choueiri, Toni K.;
Heng, Daniel Y.C.

Publication type:

Article

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial.

Published in:

2012

By:

Ross RW;
Galsky MD;
Febbo P;
Barry M;
Richie JP;
Xie W;
Fennessy FM;
Bhatt RS;
Hayes J;
Choueiri TK;
Tempany CM;
Kantoff PW;
Taplin ME;
Oh WK;
Ross, Robert W;
Galsky, Matthew D;
Febbo, Phil;
Barry, Marc;
Richie, Jerome P;
Xie, Wanling

Publication type:

journal article

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer.

Published in:

Cancer (0008543X), 2012, v. 118, n. 19, p. 4777, doi. 10.1002/cncr.27416

By:

Ross, Robert W.;
Galsky, Matthew D.;
Febbo, Phil;
Barry, Marc;
Richie, Jerome P.;
Xie, Wanling;
Fennessy, Fiona M.;
Bhatt, Rupal S.;
Hayes, Julia;
Choueiri, Toni K.;
Tempany, Clare M.;
Kantoff, Philip W.;
Taplin, Mary E.;
Oh, William K.

Publication type:

Article

The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy.

Published in:

Cancer (0008543X), 2012, v. 118, n. 2, p. 365, doi. 10.1002/cncr.26201

By:

Macfarlane, Robyn;
Heng, Daniel Y. C.;
Xie, Wanling;
Knox, Jennifer J.;
McDermott, David F.;
Rini, Brian I.;
Kollmannsberger, Christian;
Choueiri, Toni K.

Publication type:

Article

Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high‐risk localized prostate cancer.

Published in:

Prostate, 2024, v. 84, n. 4, p. 342, doi. 10.1002/pros.24653

By:

Ravi, Praful;
Kwak, Lucia;
Devlies, Wout;
Xie, Wanling;
Chipidza, Fallon;
Yang, Xiaoyu;
Bubley, Glenn;
Kaplan, Irving;
Kibel, Adam S.;
Nguyen, Paul;
Taplin, Mary‐Ellen

Publication type:

Article

Association of genetic variation of the six gene prognostic model for castration‐resistant prostate cancer with survival.

Published in:

Prostate, 2019, v. 79, n. 1, p. 73, doi. 10.1002/pros.23712

By:

Xie, Wanling;
Stopsack, Konrad H.;
Drouin, Sarah J.;
Fu, Henry;
Pomerantz, Mark M.;
Mucci, Lorelei A.;
Lee, Gwo‐Shu M.;
Kantoff, Philip W.

Publication type:

Article

Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).

Published in:

Prostate, 2018, v. 78, n. 12, p. 889, doi. 10.1002/pros.23645

By:

Francini, Edoardo;
Gray, Kathryn P.;
Xie, Wanling;
Shaw, Grace K.;
Valença, Loana;
Bernard, Brandon;
Albiges, Laurence;
Harshman, Lauren C.;
Kantoff, Philip W.;
Taplin, Mary‐Ellen;
Sweeney, Cristopher J.

Publication type:

Article

A Genetic Variation of SOD2 Does Not Determine Duration of Response to Androgen Deprivation Therapy for Prostate Cancer.

Published in:

Prostate, 2016, v. 76, n. 14, p. 1338, doi. 10.1002/pros.23220

By:

Xie, Wanling;
Drouin, Sarah;
Nakabayashi, Mari;
Pomerantz, Mark;
Lee, Gwo‐Shu Mary;
Kantoff, Philip W.;
Sharifi, Nima

Publication type:

Article

Association of Genetic Variations of Selenoprotein Genes, Plasma Selenium Levels, and Prostate Cancer Aggressiveness at Diagnosis.

Published in:

Prostate, 2016, v. 76, n. 7, p. 691, doi. 10.1002/pros.23160

By:

Xie, Wanling;
Yang, Ming;
Chan, June;
Sun, Tong;
Mucci, Lorelei A.;
Penney, Kathryn L.;
Lee, Gwo‐Shu Mary;
Kantoff, Philip W.

Publication type:

Article

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.

Published in:

Prostate, 2013, v. 73, n. 4, p. 346, doi. 10.1002/pros.22572

By:

Nguyen, Han Christine Ngoc;
Xie, Wanling;
Yang, Ming;
Hsieh, Chen‐Lin;
Drouin, Sarah;
Lee, Gwo‐Shu Mary;
Kantoff, Philip W.

Publication type:

Article

Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis.

Published in:

JAMA Network Open, 2023, v. 6, n. 11, p. e2340787, doi. 10.1001/jamanetworkopen.2023.40787

By:

Mahal, Brandon A.;
Kwak, Lucia;
Xie, Wanling;
Eastham, James A.;
James, Nicholas D.;
Sandler, Howard M.;
Feng, Felix Y.;
Brihoum, Meryem;
Fizazi, Karim;
Sweeney, Christopher;
Ravi, Praful;
D'Amico, Anthony V.

Publication type:

Article

Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Published in:

JAMA Network Open, 2023, v. 6, n. 10, p. e2336390, doi. 10.1001/jamanetworkopen.2023.36390

By:

Sayan, Mutlay;
Huang, Jiaming;
Xie, Wanling;
Chen, Ming-Hui;
Loffredo, Marian;
McMahon, Elizabeth;
Orio, Peter;
Nguyen, Paul;
D'Amico, Anthony V.

Publication type:

Article

Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.

Published in:

British Journal of Haematology, 2015, v. 169, n. 6, p. 843, doi. 10.1111/bjh.13382

By:

Varga, Cindy;
Xie, Wanling;
Laubach, Jacob;
Ghobrial, Irene M.;
O'Donnell, Elizabeth K.;
Weinstock, Matthew;
Paba‐Prada, Claudia;
Warren, Diane;
Maglio, Michelle E.;
Schlossman, Robert;
Munshi, Nikhil C.;
Raje, Noopur;
Weller, Edie;
Anderson, Kenneth C.;
Mitsiades, Constantine S.;
Richardson, Paul G.

Publication type:

Article

Formalization and Verification of PaxosStore from Process Algebra Perspective.

Published in:

Electronics (2079-9292), 2025, v. 14, n. 5, p. 823, doi. 10.3390/electronics14050823

By:

Xie, Wanling;
Yuan, Yang;
Zhu, Chenyang

Publication type:

Article

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.

Published in:

BJU International, 2011, v. 108, n. 7, p. 1086, doi. 10.1111/j.1464-410X.2010.10037.x

By:

Misra, Dipika;
Xie, Wanling;
Regan, Meredith M.;
Ross, Robert W.;
Lee, Gwo-shu;
Germain, Doris;
Kantoff, Philip W.;
Oh, William K.

Publication type:

Article

Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.

Published in:

BJU International, 2011, v. 107, n. 1, p. 126, doi. 10.1111/j.1464-410X.2010.09344.x

By:

Abe, Miyako;
Wanling Xie;
Regan, Meredith M.;
King, Irena B.;
Stampfer, Meir J.;
Kantoff, Philip W.;
Oh, William K.;
Chan, June M.

Publication type:

Article

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21068-9

By:

Bakouny, Ziad;
Braun, David A.;
Shukla, Sachet A.;
Pan, Wenting;
Gao, Xin;
Hou, Yue;
Flaifel, Abdallah;
Tang, Stephen;
Bosma-Moody, Alice;
He, Meng Xiao;
Vokes, Natalie;
Nyman, Jackson;
Xie, Wanling;
Nassar, Amin H.;
Abou Alaiwi, Sarah;
Flippot, Ronan;
Bouchard, Gabrielle;
Steinharter, John A.;
Nuzzo, Pier Vitale;
Ficial, Miriam

Publication type:

Article

Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy.

Published in:

Cancer (0008543X), 2011, v. 117, n. 12, p. 2637, doi. 10.1002/cncr.25750

By:

Heng, Daniel Y. C.;
Wanling Xie;
Bjarnason, Georg A.;
Vaishampayan, Ulka;
Min-Han Tan;
Knox, Jennifer;
Donskov, Frede;
Wood, Lori;
Kollmannsberger, Christian;
Rini, Brian I.;
Choueiri, Toni K.

Publication type:

Article

Time to Prostate-Specific Antigen Nadir Independently Predicts Overall Survival in Patients Who Have Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen-Deprivation Therapy.

Published in:

Cancer (0008543X), 2009, v. 115, n. 5, p. 981, doi. 10.1002/cncr.24064

By:

Choueiri, Toni K.;
Wanling Xie;
D'Amico, Anthony V.;
Ross, Robert W.;
Hu, Jim C.;
Pomerantz, Mark;
Regan, Meredith M.;
Taplin, Mary-Ellen;
Kantoff, Philip W.;
Sartor, Oliver;
Oh, William K.

Publication type:

Article

Efficacy of Androgen Deprivation Therapy (ADT) in Patients With Advanced Prostate Cancer.

Published in:

Cancer (0008543X), 2008, v. 112, n. 6, p. 1247, doi. 10.1002/cncr.23304

By:

Ross, Robert W.;
Wanling Xie;
Regan, Meredith M.;
Pomerantz, Mark;
Nakabayashi, Mari;
Daskivich, Timothy J.;
Sartor, Oliver;
Taplin, Mary-Ellen;
Kantoff, Philip W.;
Oh, William K.

Publication type:

Article

Higher Prostate-specific Antigen Levels Predict Improved Survival in Patients With Hormone-refractory Prostate Cancer Who Have Skeletal Metastases and Normal Serum Alkaline Phosphatase.

Published in:

Cancer (0008543X), 2007, v. 110, n. 12, p. 2709, doi. 10.1002/cncr.23111

By:

Wanling Xie;
Nakabayashi, Mari;
Regan, Meredith M.;
Oh, William K.

Publication type:

Article

Response to low‐dose ketoconazole and subsequent dose escalation to high‐dose ketoconazole in patients with androgen‐independent prostate cancer.

Published in:

Cancer (0008543X), 2006, v. 107, n. 5, p. 975

By:

Mari Nakabayashi;
Wanling Xie;
Meredith M. Regan;
David M. Jackman;
Philip W. Kantoff;
William K. Oh

Publication type:

Article

Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.

Published in:

Oncologist, 2024, v. 29, n. 8, p. 699, doi. 10.1093/oncolo/oyae072

By:

Saad, Eddy;
Gebrael, Georges;
Semaan, Karl;
Eid, Marc;
Saliby, Renée Maria;
Labaki, Chris;
Sayegh, Nicolas;
Wells, J Connor;
Takemura, Kosuke;
Ernst, Matthew Scott;
Lemelin, Audreylie;
Basappa, Naveen S;
Wood, Lori A;
Powles, Thomas;
Ernst, D Scott;
Lalani, Aly-Khan A;
Agarwal, Neeraj;
Xie, Wanling;
Heng, Daniel Y C;
Choueiri, Toni K

Publication type:

Article

A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma.

Published in:

Oncologist, 2024, v. 29, n. 4, p. 324, doi. 10.1093/oncolo/oyad298

By:

McKay, Rana R;
Leucht, Katharina;
Xie, Wanling;
Jegede, Opeyemi;
Braun, David A;
Atkins, Michael B;
Grimm, Marc-Oliver;
Choueiri, Toni K

Publication type:

Article

TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.

Published in:

Oncologist, 2024, v. 29, n. 1, p. 8, doi. 10.1093/oncolo/oyad208

By:

Zarif, Talal El;
Machaalani, Marc;
Nawfal, Rashad;
Nassar, Amin H;
Xie, Wanling;
Choueiri, Toni K;
Pomerantz, Mark

Publication type:

Article

Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma.

Published in:

Oncologist, 2023, v. 28, p. S15, doi. 10.1093/oncolo/oyad216.026

By:

Saliby, Renee Maria;
Zarif, Talal El;
Bakouny, Ziad;
Shah, Valisha;
Xie, Wanling;
Flippot, Ronan;
Denize, Thomas;
Kane, M Harry;
Madsen, Katrine;
Ficial, Miriam;
Hirsch, Laure;
Wei, Xiao;
Steinharter, John;
Harshman, Lauren;
Vaishampayan, Ulka;
Severgnini, Mariano;
McDermott, David;
Lee, Gwo-Shu Mary;
Xu, Wenxin;
Allen, Eliezer Van

Publication type:

Article

Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies.

Published in:

2020

By:

Huang, Bo;
Tian, Lu;
McCaw, Zachary R.;
Luo, Xiaodong;
Talukder, Enayet;
Rothenberg, Mace;
Xie, Wanling;
Choueiri, Toni K.;
Kim, Dae Hyun;
Wei, Lee-Jen;
Women’s Preventive Services Initiative

Publication type:

journal article

Comparison of outcomes for Hispanic and non‐Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.

Published in:

Cancer (0008543X), 2024, v. 130, n. 11, p. 2003, doi. 10.1002/cncr.35216

By:

Guram, Kripa;
Huang, Jiaming;
Mouchati, Christian;
Abdallah, Nour;
Jani, Chinmay;
Navani, Vishal;
Xie, Wanling;
El Zarif, Talal;
Adib, Elio;
Gebrael, Georges;
Agarwal, Neeraj;
Li, Haoran;
Labaki, Chris;
Labban, Muhieddine;
Ruiz Morales, Jose Manuel;
Choueiri, Toni K.;
Chin Heng, Daniel Yick;
Mittal, Abhenil;
Hansen, Aaron R.;
Rose, Brent S.

Publication type:

Article

Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial

Published in:

Cancer (0008543X), 2024, v. 130, n. 9, p. 1629, doi. 10.1002/cncr.35170

By:

McKay, Rana R.;
Xie, Wanling;
Yang, Xiaoyu;
Acosta, Andres;
Rathkopf, Dana;
Laudone, Vincent P.;
Bubley, Glenn J.;
Einstein, David J.;
Chang, Peter;
Wagner, Andrew A.;
Kane, Christopher J.;
Preston, Mark A.;
Kilbridge, Kerry;
Chang, Steven L.;
Choudhury, Atish D.;
Pomerantz, Mark M.;
Trinh, Quoc‐Dien;
Kibel, Adam S.;
Taplin, Mary‐Ellen

Publication type:

Article